PROPANC BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
PROPANC BIOPHARMA, INC. (PPCB) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 10.00 billion shares as of 2022-09-21, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2024-11-14
- 2022-09-21: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 10.00B shares.
- 2022-05-18: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 3.00B shares.
- 2015-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 400.00K shares.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 3.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2022-09-21 | 10.00B shares 10-Q · filed 2024-11-14 |
| 2022-05-18 | 3.00B shares 10-Q · filed 2024-02-20 |
| 2015-10-31 | 400.00K shares 10-Q · filed 2016-02-16 |
| 2014-12-31 | 3.00M shares 10-Q · filed 2015-02-17 |
| 2014-10-31 | 4.00M shares 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |